A cross-sectional study of more than 2000 transgender, nonbinary, and gender-diverse adults found 44% had undergone gender-affirming surgery, 82% reported high satisfaction, and 94% faced barriers, most...
Sexual and gender minority (SGM) patients as well as transgender and gender-diverse (TGD) patients historically face systemic barriers in healthcare. Gynecological cancer care must account for the unique...
A randomized clinical trial found no significant difference in breast development between cyproterone acetate and spironolactone in transgender individuals undergoing feminizing hormone therapy. However,...
Sexual and gender minority (SGM) patients as well as transgender and gender-diverse (TGD) patients historically face systemic barriers in healthcare. Gynecological cancer care must account for the unique...
Clinical guidelines emphasize both universal and risk-based strategies for HIV screening. Test your understanding of the core concepts in this focused, evidence-based 3-in-30 quiz.
A recent study linked gender-affirming hormone therapy with improved HIV outcomes in transgender populations Do you know what the barriers are to HIV care for transgender individuals? Take the quiz to test...
In 2022, there were an estimated 31,800 new HIV infections in the United States. Do you know which age group accounted for the largest number of new infections? Take the quiz to test your knowledge!
Answer Key:
1. Which factor most contributes to lower cervical cancer screening rates among sexual minority women (SMW)?
Correct Answer: Belief that they are at lower risk of cervical cancer
Margie Balfour, MD, PhD, of Connections Health Solutions, discusses the specialized LGBTQ+ services offered by the 988 Suicide Prevention & Crisis Lifeline, and what it means now that those services...
In this video, Dr Barbieri discusses a study that found that isotretinoin effectively treats acne in transgender patients undergoing masculinizing hormone therapy, though many face unique barriers—such as...
In part 3 of this 3-part episode, Jeffrey Kwong, DNP, MPH, ANP-BC, discusses the benefits of HIV pre-exposure prophylaxis (PrEP) for women in preventing HIV, strategies for eliminating HIV globally,...
In this podcast, Charles Flexner, MD, speaks about the current state of long-acting agents for the management of patients with HIV, HIV prevention and vaccines, and HIV pathogenesis and cure. Dr...
In this podcast, Jennifer Sherwood, PhD, and Elise Lankiewicz, MPH, speak about the current state of transgender inclusion in national HIV strategic plans (NSPs) globally, the results from the recent...